|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 34, 3347-3354, Copyright © 1993 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
LQ Jiang, M Jorquera and JW Streilein
Department of Microbiology and Immunology, University of Miami School of Medicine, Florida.
PURPOSE. Because immune rejection is likely to be a major barrier to successful retinal transplantation, it is important to determine whether immune privilege for allogeneic retinal grafts is a feature of the subretinal space and vitreous cavity. METHODS. Newborn neural retinas of C57BL/6 mice were implanted into the subretinal space, vitreous cavity, or subconjunctival space of eyes of adult BALB/c (disparate from C57BL/6 at major and minor histocompatibility loci). At postimplantation day 12, the recipients were evaluated for donor- specific delayed hypersensitivity and examined clinically and histologically for evidence of rejection. RESULTS. Newborn neural retinal allografts in the subconjunctival space were destroyed by postimplantation day 12 and these recipients displayed intense donor- specific delayed hypersensitivity. By contrast, grafts in the subretinal space and vitreous cavity at postimplantation day 12 were found to be well differentiated and with no evidence of inflammation; these recipients failed to display donor-specific delayed hypersensitivity. Moreover, their spleens contained regulatory T cells that suppressed donor-specific delayed hypersensitivity in naive syngeneic recipients. CONCLUSIONS. Allogeneic newborn neural retinal grafts implanted in the subretinal space and vitreous cavity experience immune privilege and induce deviant immune responses resembling anterior chamber associated immune deviation.
This article has been cited by other articles:
![]() |
J. Sancho-Pelluz, K. A. Wunderlich, U. Rauch, F. J. Romero, T. van Veen, G. A. Limb, P. R. Crocker, and M.-T. Perez Sialoadhesin Expression in Intact Degenerating Retinas and Following Transplantation Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5602 - 5610. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Ng, N. Kitaichi, and A. W. Taylor In Vitro Generated Autoimmune Regulatory T Cells Enhance Intravitreous Allogeneic Retinal Graft Survival Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5112 - 5117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zamiri, Q. Zhang, and J. W. Streilein Vulnerability of Allogeneic Retinal Pigment Epithelium to Immune T-Cell-Mediated Damage In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lund, S. J. Ono, D. J. Keegan, and J. M. Lawrence Retinal transplantation: progress and problems in clinical application J. Leukoc. Biol., August 1, 2003; 74(2): 151 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hori, T. F. Ng, M. Shatos, H. Klassen, J. W. Streilein, and M. J. Young Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts Stem Cells, July 1, 2003; 21(4): 405 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. McKenna, Y. Xu, and J. A. Kapp Injection of Soluble Antigen into the Anterior Chamber of the Eye Induces Expansion and Functional Unresponsiveness of Antigen-Specific CD8+ T Cells J. Immunol., November 15, 2002; 169(10): 5630 - 5637. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu and J. A. Kapp {gamma}{delta} T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3473 - 3479. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Gregerson and C. Dou Spontaneous Induction of Immunoregulation by an Endogenous Retinal Antigen Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2984 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Ng and J. W. Streilein Light-Induced Migration of Retinal Microglia into the Subretinal Space Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3301 - 3310. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kee, S. Sohn, and J.-M. Hwang Stromelysin Gene Transfer into Cultured Human Trabecular Cells and Rat Trabecular Meshwork In Vivo Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2856 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wasselius and F. Ghosh Adult Rabbit Retinal Transplants Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2632 - 2638. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Repp, E. S. Mayhew, S. Apte, and J. Y. Niederkorn Human Uveal Melanoma Cells Produce Macrophage Migration-Inhibitory Factor to Prevent Lysis by NK Cells J. Immunol., July 15, 2000; 165(2): 710 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, M. Takeuchi, and W. Streilein Participation of Pigment Epithelium of Iris and Ciliary Body in Ocular Immune Privilege. 1. Inhibition of T-Cell Activation In Vitro by Direct Cell-to-Cell Contact Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 811 - 821. [Abstract] [Full Text] |
||||
![]() |
H. Wenkel, P. W. Chen, B. R. Ksander, and J. W. Streilein Immune Privilege Is Extended, then Withdrawn, from Allogeneic Tumor Cell Grafts Placed in the Subretinal Space Invest. Ophthalmol. Vis. Sci., December 1, 1999; 40(13): 3202 - 3208. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Oganesian, K. Gabrielian, J. T. Ernest, and S. C. Patel A New Model of Retinal Pigment Epithelium Transplantation With Microspheres Arch Ophthalmol, September 1, 1999; 117(9): 1192 - 1200. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ma and J. W. Streilein T Cell Immunity Induced by Allogeneic Microglia in Relation to Neuronal Retina Transplantation J. Immunol., April 15, 1999; 162(8): 4482 - 4489. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bodaghi, O. Goureau, D. Zipeto, L. Laurent, J.-L. Virelizier, and S. Michelson Role of IFN-{gamma}-Induced Indoleamine 2,3 Dioxygenase and Inducible Nitric Oxide Synthase in the Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells J. Immunol., January 15, 1999; 162(2): 957 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R R ALI, M B REICHEL, D M HUNT, and S S BHATTACHARYA Gene therapy for inherited retinal degeneration Br. J. Ophthalmol., September 1, 1997; 81(9): 795 - 801. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |